WELLS FARGO & COMPANY/MN
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 72971
SAN FRANCISCO, CA
Position in ARCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$200,873
+$54,163 QoQ
Shares Held
29,892
+57.3% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 133 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. ARCT ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ARCT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,873 | 29,892 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $146,710 | 19,004 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $253,309 | 41,323 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $612,520 | 33,235 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $292,022 | 22,446 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $197,269 | 18,628 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,182,196 | 69,664 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,436,210 | 61,879 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,772,338 | 72,786 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,419,889 | 71,658 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,300,805 | 72,972 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,828,766 | 110,715 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,405,103 | 153,595 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $3,850,491 | 160,638 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,977,908 | 116,622 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,731,147 | 184,288 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,772,583 | 176,149 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,222,446 | 156,619 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,477,986 | 120,994 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,663,253 | 139,457 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,000,495 | 118,218 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,465,850 | 108,132 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $6,132,715 | 141,372 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,262,586 | 76,051 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,042,678 | 65,098 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $215,523 | 15,859 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||